Pamela Fletcher
Known title: DirectorCIK: 0001711035
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.
Transaction History
| LITE | ▲ Buy | Grant | 108 | $0 | 7/15/2026 | View on chart |
| LITE | ▼ Sell | Open Market | 1,578 | $1.5M | 5/15/2026 | View on chart |
| LITE | ▼ Sell | Open Market | 1,577 | $1.6M | 5/14/2026 | View on chart |
| CC | ▲ Buy | Grant | 7,182 | $0 | 5/6/2026 | View on chart |
| LITE | ▲ Buy | Grant | 1,283 | $0 | 11/19/2025 | View on chart |
| LITE | ▲ Buy | Grant | 2,810 | $0 | 11/19/2025 | View on chart |
| LITE | ▼ Sell | Open Market | 3,421 | $936K | 11/19/2025 | View on chart |
| LITE | ▼ Sell | Open Market | 579 | $145K | 11/17/2025 | View on chart |
| CC | ▲ Buy | Grant | 14,096 | $0 | 4/22/2025 | View on chart |
| LITE | ▲ Buy | Grant | 3,313 | $0 | 11/20/2024 | View on chart |
| CC | ▲ Buy | Grant | 8,547 | $0 | 8/6/2024 | View on chart |
| CC | ▲ Buy | Grant | 1,454 | $0 | 5/8/2024 | View on chart |
| LITE | ▲ Buy | Grant | 5,416 | $0 | 11/17/2023 | View on chart |
| LITE | ▲ Buy | Grant | 1,739 | $0 | 2/22/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Lumentum Earnings Preview Amid AI Infrastructure Demand
Investors are watching Lumentum ahead of its upcoming earnings report, with attention on how strong AI infrastructure demand affects the company's outlook. Recent coverage notes that Lumentum has significant capacity commitments through 2029, a factor some analysts view as positive for supply chain partners like GlobalFoundries. The stock is currently trading near its 52-week high, reflecting high expectations for performance in the AI sector.
Lumentum Earnings Preview Amid AI Infrastructure Demand. Investors are watching Lumentum ahead of its upcoming earnings report, with attention on how strong AI infrastructure demand affects the company's outlook. Recent coverage notes that Lumentum has significant capacity commitments through 2029, a factor some analysts view as positive for supply chain partners like GlobalFoundries. The stock is currently trading near its 52-week high, reflecting high expectations for performance in the AI sector.